Anika Therapeutics Reports Robust Financial Performance and Continued Progress on Key Fronts in Third Quarter of 2015

Go back to Anika Therapeutics Reports Robust Financial Performance and Continued Progress on Key Fronts in Third Quarter of 2015
Anika Therapeutics, Inc. (NASDAQ: ANIK) Delayed: 14.59 --0 (-0%)
Previous Close $14.59    52 Week High $54.96 
Open $14.59    52 Week Low $35.07 
Day High $14.59    P/E 11.58 
Day Low $14.59    EPS $1.26 
Volume